Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice.
Female sex steroids and glia cells: Impact on multiple sclerosis lesion formation and fine tuning of the local neurodegenerative cellular network.
Differential patterns of spinal cord and brain atrophy in NMO and MS.
Mesenchymal Stem Cells and Induced Pluripotent Stem Cells as Therapies for Multiple Sclerosis.
Corpus Callosum Atrophy Correlates with Gray Matter Atrophy in Patients with Multiple Sclerosis.
New data identify an increasing sex ratio of multiple sclerosis in Sweden.
Impaired ambulation and steroid therapy impact negatively on bone health in multiple sclerosis.
Mitochondrial immobilization mediated by syntaphilin facilitates survival of demyelinated axons.
How Patients With Multiple Sclerosis Perceive Cognitive Slowing.
[Multiple sclerosis in Argentina. Systematic review and meta-analysis].
Accurately diagnosing and comprehensively managing MS.
The effect of delayed percutaneous nephrolithotomy on the risk of bacteremia and sepsis in patients with neuromuscular disorders.
Surgery and risk for multiple sclerosis: a systematic review and meta-analysis of case-control studies.
A Sphingosine-1-Phosphate Receptor 1-Directed Agonist Reduces Central Nervous System Inflammation in a Plasmacytoid Dendritic Cell-Dependent Manner.
Autobiographical memory in multiple sclerosis patients: Assessment and cognitive facilitation.
Potential anti-tumor effects of FTY720 associated with PP2A activation: a brief review.
A Multiple Sclerosis-Associated Variant of CBLB Links Genetic Risk with Type I IFN Function.
NAD(+) protects against EAE by regulating CD4(+) T-cell differentiation.
Early CNS neurodegeneration in radiologically isolated syndrome.
Seizure Drug May Help in MS Eye Disease
Incorporating real-world clinical practice in multiple sclerosis economic evaluations.
The miR-30a Negatively Regulates IL-17-Mediated Signal Transduction by Targeting Traf3ip2.
Enhanced remyelination following lysolecithin-induced demyelination in mice under treatment with fingolimod (FTY720).
Human Endogenous Retrovirus HERV-Fc1 Association with Multiple Sclerosis Susceptibility: A Meta-Analysis.
Cognitive deficits in pediatric-onset multiple sclerosis: what does the future hold?

Pages